ArticleBiosensors2026
PathoSafe: Sub-1 KB Out-of-Distribution Rejection and Cluster-Aware Certification for Point-of-Care Pathogen Biosensing.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A point-of-care pathogen-microscopy readout must signal when a sample falls outside what its detector was trained on. PathoSafe is an 816-byte int8-projection low-rank Mahalanobis out-of-distribution (OOD) head reading a frozen detector's penultimate feature. It reaches a cross-site area under the receiver operating characteristic curve (AUROC) of 0.980 and multi-source AUROC of 0.964 (parasitic-egg-dominated), within 0.01 of a 16,896-byte full-precision dense baseline, and adds a measured 30.76 µs and 816 bytes of read-only memory (ROM) constants on an STM32H743 development board, so abstention adds only a small measured cost on-chip. The advantage is the trunk feature rather than the integer form. Certification is the harder problem and carries our central result: slide clustering silently breaks the standard independent-sample certificate, since distribution-free risk control assumes exchangeable samples that patch-clustered medical data do not supply. On a degraded-input risk certificate, the naive cell-level version holds on only 20% of leakage-free re-splits, whereas the correct slide-level one is valid at 0.266 with its width set by the slide count rather than by any bound we evaluate. The deployed threshold inherits this less severely. A Hoeffding-Bentkus budget gives an illustrative count of 38 independent slides under the stated assumptions (35 when five seeds are used), which is about 1.3× what this benchmark provides. We release that leakage-free slide-disjoint benchmark: an in-distribution malaria task with cross-site (BBBC041) and multi-source (SIPaKMeD, parasitic egg, white blood cells) regimes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.